Your browser doesn't support javascript.
loading
Medicare's National Coverage Determination for Aducanumab - A One-Off or a Pragmatic Path Forward?
Dhruva, Sanket S; Ramachandran, Reshma; Ross, Joseph S.
Afiliação
  • Dhruva SS; From the Section of Cardiology, Department of Medicine, University of California, San Francisco, School of Medicine, the Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, and the San Francisco Veterans Affairs Health Care System - all in San Francisco (S.S.D.); and the National Clinician Scholars Program, the Section of General Internal Medicine, and the Yale Collaboration for Research Integrity and Transparency, Department of Internal Medicine, Yale Sch
  • Ramachandran R; From the Section of Cardiology, Department of Medicine, University of California, San Francisco, School of Medicine, the Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, and the San Francisco Veterans Affairs Health Care System - all in San Francisco (S.S.D.); and the National Clinician Scholars Program, the Section of General Internal Medicine, and the Yale Collaboration for Research Integrity and Transparency, Department of Internal Medicine, Yale Sch
  • Ross JS; From the Section of Cardiology, Department of Medicine, University of California, San Francisco, School of Medicine, the Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, and the San Francisco Veterans Affairs Health Care System - all in San Francisco (S.S.D.); and the National Clinician Scholars Program, the Section of General Internal Medicine, and the Yale Collaboration for Research Integrity and Transparency, Department of Internal Medicine, Yale Sch
N Engl J Med ; 387(17): 1539-1541, 2022 10 27.
Article em En | MEDLINE | ID: mdl-36301560

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicare / Cobertura do Seguro / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicare / Cobertura do Seguro / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2022 Tipo de documento: Article